Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 21, 2006

View Archived Issues

Proof-of-concept milestone in phase Ib study of HCV-796

Milestone achieved in Evotec and Takeda's Alzheimer's disease collaboration

Chromos advances development of CHR-1103

NTx-265 yields recovery of lost neurological function in rodent model of stroke

Overcoming TKI resistance via ADAM inhibition

NNZ-2566 set to begin phase II for traumatic brain injury in 2007

Algeta and Affibody to develop novel targeted radiotherapeutics

New imaging agents for ocular disorders and cancer disclosed in recent GE and Yeda patents

HIV integrase inhibitor 364735 completes initial phase I study

Recent Tanabe and Neurogen patents report novel analgesic agents

Recent Tanabe and Dainippon patents describe new antidiabetic agents

Recent Tibotec and Pfizer patents report novel therapeutic agents for HIV infection

5F-203 triggers single-strand DNA breaks and cell cycle arrest in MCF7 cells

Favorable pharmacokinetics in monkeys warrant further development of Dioxolane T

TMC-278-ketoconazole interaction detailed in healthy subjects

Pharmacokinetics of apricitabine similar in HIV-positive and -negative subjects

Vicriviroc pharmacokinetics, phase II results reported

New data on TMC-114, TMC-125 and their combination presented

Safety and activity of fontolizumab evaluted in Crohn's disease patients

BB-10153 induces high rate of normal flow in ST elevation myocardial infarction

Actonel approved for men with osteoporosis

Remicade approved for expanded indication in psoriatic arthritis

Vasovist recommended for approval in Australia

Abilify Discmelt launched in U.S.

Plavix approved for use in patients with STEMI

Keppra approved in Europe for newly diagnosed epilepsy patients

Rhucin MAA accepted for review

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...